In-vivo pharmacology of Trace-Amine Associated Receptor 1

European Journal of Pharmacology

Volumn 763, Issue , 2015, Pages 136-142

  Lam, Vincent M ^a   Espinoza, Stefano ^b   Gerasimov, Andrey S ^c   Gainetdinov, Raul R ^c,d   Salahpour, Ali ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

Author keywords

Dopamine; Neurological disorders; TAAR1; Trace amines

Indexed keywords

MEMBRANE RECEPTOR; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG; AMINE; DOPAMINE; G PROTEIN COUPLED RECEPTOR; LIGAND; TRACE AMINE-ASSOCIATED RECEPTOR 1;

BINDING AFFINITY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BRAIN SLICE; CELL MIGRATION; CYCLIC POTENTIOMETRY; DOPAMINERGIC TRANSMISSION; DORSAL RAPHE NUCLEUS; ELECTROPHYSIOLOGY; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; IN SITU HYBRIDIZATION; IN VIVO STUDY; INTERNALIZATION; LIGAND BINDING; LOCUS CERULEUS; MOLECULAR DOCKING; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ANIMAL; DRUG EFFECTS; METABOLISM; PHARMACOLOGY;

AMINES; ANIMALS; DOPAMINE; HUMANS; LIGANDS; PHARMACOLOGICAL PHENOMENA; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84942987446     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.06.026     Document Type: Article

References (77)

1. C. Achat-Mendes, L.J. Lynch, K.A. Sullivan, E.J. Vallender, and G.M. Miller Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1 Pharmacol. Biochem. Behav. 101 2012 201 207
2. A. Babusyte, M. Kotthoff, J. Fiedler, and D. Krautwurst Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2 J. Leukoc. Biol. 93 2013 387 394
3. L.S. Barak, A. Salahpour, X. Zhang, B. Masri, T.D. Sotnikova, A.J. Ramsey, J.D. Violin, R.J. Lefkowitz, M.G. Caron, and R.R. Gainetdinov Pharmacological characterization of membrane-expressed human Trace Amine-Associated Receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor Mol. Pharmacol. 74 2008 585 594
4. M.D. Berry Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators J. Neurochem. 90 2004 257 271
5. B. Borowsky, N. Adham, K.A. Jones, R. Raddatz, R. Artymyshyn, K.L. Ogozalek, M.M. Durkin, P.P. Lakhlani, J.A. Bonini, S. Pathirana, N. Boyle, X. Pu, E. Kouranova, H. Lichtblau, F.Y. Ochoa, T.A. Branchek, and C. Gerald Trace amines: identification of a family of mammalian G protein-coupled receptors Proc. Natl. Acad. Sci. USA 98 2001 8966 8971
6. A. Bradaia, G. Trube, H. Stalder, R.D. Norcross, L. Ozmen, J.G. Wettstein, A. Pinard, D. Buchy, M. Gassmann, M.C. Hoener, and B. Bettler The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system Proc. Natl. Acad. Sci. USA 106 2009 20081 20086
7. J.R. Bunzow, M.S. Sonders, S. Arttamangkul, L.M. Harrison, G. Zhang, D.I. Quigley, T. Darland, K.L. Suchland, S. Pasumamula, J.L. Kennedy, S.B. Olson, R.E. Magenis, S.G. Amara, and D.K. Grandy Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor Mol. Pharmacol. 60 2001 1181 1188
8. W.T. Carpenter, and R.W. Buchanan Schizophrenia N. Engl. J. Med. 330 1994 681 690
9. E. Cichero, S. Espinoza, R.R. Gainetdinov, L. Brasili, and P. Fossa Insights into the structure and pharmacology of the Human Trace Amine-Associated Receptor 1 (hTAAR1): homology modelling and docking studies Chem. Biol. Drug Des. 81 2013 509 516
10. E. Cichero, S. Espinoza, S. Franchini, S. Guariento, L. Brasili, R.R. Gainetdinov, and P. Fossa Further insights into the pharmacology of the human trace amine-associated receptors: discovery of novel ligands for TAAR1 by a virtual screening approach Chem. Biol. Drug Des. 84 2014 712 720
11. B. Costall, R.J. Naylor, and V. Nohria Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity Eur. J. Pharmacol. 50 1978 39 50
12. R. Cotter, Y. Pei, L. Mus, A. Harmeier, R.R. Gainetdinov, M.C. Hoener, and J.J. Canales The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects Front. Neurosci. 9 2015 39
13. A. Dewan, R. Pacifico, R. Zhan, D. Rinberg, and T. Bozza Non-redundant coding of aversive odours in the main olfactory pathway Nature 497 2013 486 489
14. B. Di Cara, R. Maggio, G. Aloisi, J.-M. Rivet, E.G. Lundius, T. Yoshitake, P. Svenningsson, M. Brocco, A. Gobert, L. De Groote, L. Cistarelli, S. Veiga, C. De Montrion, M. Rodriguez, J.-P. Galizzi, B.P. Lockhart, F. Coge, J. a Boutin, P. Vayer, P.M. Verdouw, L. Groenink, and M.J. Millan Genetic deletion of Trace Amine 1 Receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA) J. Neurosci. 31 2011 16928 16940
15. J. Dinter, J. Mühlhaus, C.L. Wienchol, C.-X. Yi, D. Nürnberg, S. Morin, A. Grüters, J. Köhrle, T. Schöneberg, M. Tschöp, H. Krude, G. Kleinau, and H. Biebermann Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5 PLoS One 10 2015 e0117774
16. J. Duan, M. Martinez, A.R. Sanders, C. Hou, N. Saitou, T. Kitano, B.J. Mowry, R.R. Crowe, J.M. Silverman, D.F. Levinson, and P.V. Gejman Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia Am. J. Hum. Genet. 75 2004 624 638
17. Espinoza, S., Gainetdinov, R.R., 2014. Neuronal functions and emerging pharmacology of TAAR1, topics in medicinal chemistry, pp. 1-20. http://dx.doi.org/10.1007/7355-2014-78
18. S. Espinoza, B. Masri, A. Salahpour, and R.R. Gainetdinov BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling Methods Mol. Biol. 964 2013 107 122
19. S. Espinoza, A. Salahpour, B. Masri, T.D. Sotnikova, M. Messa, L.S. Barak, M.G. Caron, and R.R. Gainetdinov Functional interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor Mol. Pharmacol. 80 2011 416 425
20. S. Espinoza, V. Ghisi, M. Emanuele, D. Leo, I. Sukhanov, T.D. Sotnikova, E. Chieregatti, and R.R. Gainetdinov Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1 Neuropharmacology 93 2015 308 313
21. S. Espinoza, G. Lignani, L. Caffino, S. Maggi, I. Sukhanov, D. Leo, L. Mus, M. Emanuele, G. Ronzitti, A. Harmeier, L. Medrihan, T.D. Sotnikova, E. Chieregatti, M.C. Hoener, F. Benfenati, V. Tucci, F. Fumagalli, and R.R. Gainetdinov TAAR1 modulates cortical glutamate NMDA receptor function Neuropsychopharmacology 2015
22. G. Galley, H. Stalder, A. Goergler, M.C. Hoener, and R.D. Norcross Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012 Bioorg. Med. Chem. Lett. 22 2012 5244 5248
23. E.A. Gozal, B.E. O'Neill, M.A. Sawchuk, H. Zhu, M. Halder, C.-C. Chou, and S. Hochman Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord Front. Neural Circuits 8 2014 134
24. D.K. Grandy Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol. Ther. 116 2007 355 390
25. J. Grimsby, M. Toth, K. Chen, T. Kumazawa, L. Klaidman, J.D. Adams, F. Karoum, J. Gal, and J.C. Shih Increased stress response and beta-phenylethylamine in MAOB-deficient mice Nat. Genet. 17 1997 206 210
26. J.H. Harkness, X. Shi, A. Janowsky, and T.J. Phillips Trace Amine-Associated Receptor 1 regulation of methamphetamine intake and related traits Neuropsychopharmacology 2015 1 34
27. R. Irannejad, J.C. Tomshine, J.R. Tomshine, M. Chevalier, J.P. Mahoney, J. Steyaert, S.G.F. Rasmussen, R.K. Sunahara, H. El-Samad, B. Huang, and M. von Zastrow Conformational biosensors reveal GPCR signalling from endosomes Nature 495 2013 534 538
28. R.B. Jarrett, M. Schaffer, D. McIntire, A. Witt-Browder, D. Kraft, and R.C. Risser Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial Arch. Gen. Psychiatry 56 1999 431 437
29. D. Leo, L. Mus, S. Espinoza, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors Neuropharmacology 81 2014 283 291
30. S.D. Liberles, and L.B. Buck A second class of chemosensory receptors in the olfactory epithelium Nature 442 2006 645 650
31. L. Lindemann, and M.C. Hoener A renaissance in trace amines inspired by a novel GPCR family Trends Pharmacol. Sci. 26 2005 274 281
32. L. Lindemann, C.A. Meyer, K. Jeanneau, A. Bradaia, L. Ozmen, H. Bluethmann, B. Bettler, J.G. Wettstein, E. Borroni, J.-L. Moreau, and M.C. Hoener Trace amine-associated receptor 1 modulates dopaminergic activity J. Pharmacol. Exp. Ther. 324 2008 948 956
33. I.S. Liu, I. Kusumi, C. Ulpian, T. Tallerico, and P. Seeman A serotonin-4 receptor-like pseudogene in humans Brain Res. Mol. Brain Res. 53 1998 98 103
34. X. Liu, D.K. Grandy, and A. Janowsky Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1 J. Pharmacol. Exp. Ther. 350 2014 124 129
35. L.J. Lynch, K.A. Sullivan, E.J. Vallender, J.K. Rowlett, D.M. Platt, and G.M. Miller Trace amine associated receptor 1 modulates behavioral effects of ethanol Subst. Abus. 7 2013 117 126
36. J.J. Maguire, W.A.E. Parker, S.M. Foord, T.I. Bonner, R.R. Neubig, and A.P. Davenport International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature Pharmacol. Rev. 61 2009 1 8
37. G.M. Miller The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity J. Neurochem. 116 2011 164 176
38. G.M. Miller Avenues for the development of therapeutics that target Trace Amine Associated Receptor 1 (TAAR1) J. Med. Chem. 1 2012 1809 1814
39. G.M. Miller, C.D. Verrico, A. Jassen, M. Konar, H. Yang, H. Panas, M. Bahn, R. Johnson, and B.K. Madras Primate trace amine receptor 1 modulation by the dopamine transporter J. Pharmacol. Exp. Ther. 313 2005 983 994
40. Y. Miura Plasma beta-phenylethylamine in Parkinson's disease Kurume Med. J. 47 2000 267 272
41. D.L. Murphy, F. Karoum, D. Pickar, R.M. Cohen, S. Lipper, A.M. Mellow, P.N. Tariot, and T. Sunderland Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline) J. Neural Transm. Suppl. 52 1998 39 48
42. F.A.J. Muskiet, C.G. Thomasson, A.M. Gerding, D.C. Fremouw-Ottevangers, G.T. Nagel, and B.G. Wolthers Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards Clin. Chem. 25 1979 453 460
43. D.A. Nelson, M.D. Tolbert, S.J. Singh, and K.L. Bost Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes J. Neuroimmunol. 192 2007 21 30
44. C.U. Pae, A. Drago, J.J. Kim, A.A. Patkar, T.Y. Jun, D. De Ronchi, and A. Serretti TAAR6 variations possibly associated with antidepressant response and suicidal behavior Psychiatry Res. 180 2010 20 24
45. M.W. Panas, Z. Xie, H.N. Panas, M.C. Hoener, E.J. Vallender, and G.M. Miller Trace amine associated receptor 1 signaling in activated lymphocytes J. Neuroimmune Pharmacol. 7 2012 866 876
46. Y. Pei, J. Lee, D. Leo, R.R. Gainetdinov, M.C. Hoener, and J.J. Canales Activation of the Trace Amine-Associated Receptor 1 prevents relapse to Cocaine seeking Neuropsychopharmacology 39 2014 1 33
47. D. Peleg-Raibstein, I. Knuesel, and J. Feldon Amphetamine sensitization in rats as an animal model of schizophrenia Behav. Brain Res. 191 2008 190 201
48. S.G. Potkin, F. Karoum, L.W. Chuang, H.E. Cannon-Spoor, I. Phillips, and R.J. Wyatt Phenylethylamine in paranoid chronic schizophrenia Science 206 1979 470 471
49. A.H. Rajput, M.E. Fenton, T. Di Paolo, H. Sitte, C. Pifl, and O. Hornykiewicz Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off Park. Relat. Disord. 10 2004 221 226
50. E.A. Reese, J.R. Bunzow, S. Arttamangkul, M.S. Sonders, and D.K. Grandy Trace Amine-Associated Receptor 1 displays species- dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine Pharmacology 321 2007 178 186
51. E.A. Reese, Y. Norimatsu, M.S. Grandy, K.L. Suchland, J.R. Bunzow, and D.K. Grandy Exploring the determinants of trace amine-associated receptor 1′s functional selectivity for the stereoisomers of amphetamine and methamphetamine J. Med. Chem. 57 2014 378 390
52. F.G. Revel, C.A. Meyer, A. Bradaia, K. Jeanneau, E. Calcagno, C.B. André, M. Haenggi, M.-T. Miss, G. Galley, R.D. Norcross, R.W. Invernizzi, J.G. Wettstein, J.-L. Moreau, and M.C. Hoener Brain-specific overexpression of Trace Amine-Associated Receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine Neuropsychopharmacology 37 2012 2580 2592
53. F.G. Revel, J.-L. Moreau, R.R. Gainetdinov, A. Bradaia, T.D. Sotnikova, R. Mory, S. Durkin, K.G. Zbinden, R. Norcross, C.A. Meyer, V. Metzler, S. Chaboz, L. Ozmen, G. Trube, B. Pouzet, B. Bettler, M.G. Caron, J.G. Wettstein, and M.C. Hoener TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Proc. Natl. Acad. Sci. USA 108 2011 8485 8490
54. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Ferragud, C. Velázquez-Sánchez, T.D. Sotnikova, S.R. Morairty, A. Harmeier, K. Groebke Zbinden, R.D. Norcross, A. Bradaia, T.S. Kilduff, B. Biemans, B. Pouzet, M.G. Caron, J.J. Canales, T.L. Wallace, J.G. Wettstein, and M.C. Hoener Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics Biol. Psychiatry 72 2012 934 942
55. F.G. Revel, J.-L. Moreau, B. Pouzet, R. Mory, A. Bradaia, D. Buchy, V. Metzler, S. Chaboz, K. Groebke Zbinden, G. Galley, R.D. Norcross, D. Tuerck, A. Bruns, S.R. Morairty, T.S. Kilduff, T.L. Wallace, C. Risterucci, J.G. Wettstein, and M.C. Hoener A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight Mol. Psychiatry 18 2012 543 556
56. A. Rickli, S. Kopf, M.C. Hoener, and M.E. Liechti Pharmacological profile of novel psychoactive benzofurans Br. J. Pharmacol. 172 2015 3412 3425
57. H. Sabelli, P. Fink, J. Fawcett, and C. Tom Sustained antidepressant effect of PEA replacement J. Neuropsychiatry Clin. Neurosci. 8 1996 168 171
58. A. Salahpour, S. Espinoza, B. Masri, V. Lam, L.S. Barak, and R.R. Gainetdinov BRET biosensors to study GPCR biology, pharmacology, and signal transduction Front. Endocrinol. 3 2012 105
59. M. Sandler, C.R. Ruthven, B.L. Goodwin, and A. Coppen Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness Clin. Chim. Acta 93 1979 169 171
60. T.S. Scanlan, K.L. Suchland, M.E. Hart, G. Chiellini, Y. Huang, P.J. Kruzich, S. Frascarelli, D. a Crossley, J.R. Bunzow, S. Ronca-Testoni, E.T. Lin, D. Hatton, R. Zucchi, and D.K. Grandy 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone Nat. Med. 10 2004 638 642
61. S. Shirkande, O&apos, R. Reilly, B. Davis, D. Durden, and D. Malcom Plasma phenylethylamine levels of schizophrenic patients Can. J. Psychiatry 40 1995 221
62. T. Siirtola, V. Sonninen, and U.K. Rinne Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations Clin. Neurol. Neurosurg. 78 1975 77 88
63. T.D. Sotnikova, J.-M. Beaulieu, S. Espinoza, B. Masri, X. Zhang, A. Salahpour, L.S. Barak, M.G. Caron, and R.R. Gainetdinov The dopamine metabolite 3-methoxytyramine is a neuromodulator PLoS One 5 2010 e13452
64. I. Sukhanov, S. Espinoza, D.S. Yakovlev, M.C. Hoener, T.D. Sotnikova, and R.R. Gainetdinov TAAR1-dependent effects of apomorphine in mice Int. J. Neuropsychopharmacol. 17 2014 1683 1693
65. A. Tadevosyan, G. Vaniotis, B.G. Allen, T.E. Hébert, and S. Nattel G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function J. Physiol. 590 2012 1313 1330
66. K.R. Tallman, and D.K. Grandy A decade of pharma discovery delivers new tools targeting Trace Amine-Associated Receptor 1 Neuropsychopharmacology 37 2012 2553 2554
67. D.A. Thorn, C. Zhang, Y. Zhang, and J.X. Li The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats Neurosci. Lett. 566 2014 67 71
68. D.A. Thorn, L. Jing, Y. Qiu, A.M. Gancarz-Kausch, C.M. Galuska, D.M. Dietz, Y. Zhang, and J.-X. Li Effects of the Trace Amine-Associated Receptor 1 Agonist RO5263397 on abuse-related effects of Cocaine in rats Neuropsychopharmacology 18 2014 1 8
69. D.B. Wainscott, S.P. Little, T. Yin, Y. Tu, V.P. Rocco, J.X. He, and D.L. Nelson Pharmacologic characterization of the cloned human Trace Amine-Associated Receptor1 (TAAR1) and evidence for species differences with the rat TAAR1 Pharmacology 320 2007 475 485
70. T.D. Wolinsky, C.J. Swanson, K.E. Smith, H. Zhong, B. Borowsky, P. Seeman, T. Branchek, and C.P. Gerald The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia Genes Brain Behav. 6 2007 628 639
71. Z. Xie, and G.M. Miller Trace Amine-Associated Receptor 1 Is a modulator of the dopamine transporter Pharmacology 321 2007 128 136
72. Z. Xie, and G.M. Miller A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain J. Pharmacol. Exp. Ther. 330 2009 316 325
73. Z. Xie, and G.M. Miller Trace amine-associated receptor 1 as a monoaminergic modulator in brain Biochem. Pharmacol. 78 2009 1095 1104
74. Z. Xie, S.V. Westmoreland, M.E. Bahn, G. Chen, H. Yang, E.J. Vallender, W. Yao, B.K. Madras, and G.M. Miller Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro J. Pharmacol. Exp. Ther. 321 2007 116 127
75. J. Zhang, R. Pacifico, D. Cawley, P. Feinstein, and T. Bozza Ultrasensitive detection of amines by a trace amine-associated receptor J. Neurosci. 33 2013 3228 3239
76. G. Zhou, H. Shoji, S. Yamada, and T. Matsuishi Decreased beta-phenylethylamine in CSF in Parkinson's disease J. Neurol. Neurosurg. Psychiatry 63 1997 754 758
77. R. Zucchi, G. Chiellini, T.S. Scanlan, and D.K. Grandy Trace amine-associated receptors and their ligands Br. J. Pharmacol. 149 2006 967 978